De Novo accesses Structural's ProMax

Structural Bioinformatics (San Diego, Calif.) granted De Novo Pharmaceuticals ( Cambridge, U.K.) access to multiple therapeutic target classes in its SBdBase. The product is part of Structural's ProMa...